get a key
steadybase-$ person Shelley Toonan
nameShelley Toonan
roleCFO
company RxSight Inc. RXST
linkedin none on file
contactnot published
filingsnone on file
quotes
SG&A expenses in the second quarter of 2023 were $18.2 million, up 27%, versus $14.4 million in the year-ago quarter, reflecting increased expenses in sales and marketing, personnel costs, and travel.

Aug 7, 2023 / CFO / receipt, needs a key / Shelley Toonan, CFO | earnings call 2023-08-07 | transcript cf3df27a-1c41-482b-8140-70f008cd8441 | chars 4437-4637 | segment 4

SD&A expenses in the first quarter of 2023 were $16.3 million, up 19% versus $13.6 million in the year-ago quarter, reflecting increased expenses in sales and marketing personnel costs and travel and increased non-cash stock-based compensation expense in sales, marketing, and G&A.

May 9, 2023 / CFO / receipt, needs a key / Shelley Toonan, CFO | earnings call 2023-05-09 | transcript e42a2c40-4b2a-4227-845a-cafea00c219b | chars 4271-4552 | segment 4

steadybase-$